Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study

scientific article published on 25 April 2013

Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1185/03007995.2013.792246
P698PubMed publication ID23551064

P2093author name stringM-L Heskamp
C Maihofner
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectpatientQ181600
neuropathic painQ2798704
P304page(s)673-683
P577publication date2013-04-25
P1433published inCurrent Medical Research and OpinionQ5195063
P1476titleProspective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study
P478volume29

Reverse relations

cites work (P2860)
Q34301601A capsaicin (8%) patch in the treatment of severe persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled trial
Q38815838An overview of treatment approaches for chronic pain management
Q38669012Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain
Q41057630Capsaicin 8% patch treatment for amputation stump and phantom limb pain: a clinical and functional MRI study
Q38988562Capsaicin and Its Role in Chronic Diseases.
Q26744369Capsaicin, Nociception and Pain
Q33588849Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study
Q39150097Effects of High-Dose Capsaicin on TMD Subjects: A Randomized Clinical Study.
Q51249216Evolution of Capsaicinoids in Peter Pepper (Capsicum annuum var. annuum) During Fruit Ripening.
Q37575526Feasibility of Topical Applications of Natural High-Concentration Capsaicinoid Solutions in Patients with Peripheral Neuropathic Pain: A Retrospective Analysis
Q34726023High-Dose Capsaicin for the Treatment of Neuropathic Pain: What We Know and What We Need to Know
Q50072130Management of chronic neuropathic pain with single and compounded topical analgesics
Q28073412Neuropathic low back pain in clinical practice
Q49503498Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice
Q91822729Patients' Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice
Q38221257Pharmacology of the capsaicin receptor, transient receptor potential vanilloid type-1 ion channel.
Q39191235Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain.
Q42318004Quantitative Thermal Testing Profiles as a Predictor of Treatment Response to Topical Capsaicin in Patients with Localized Neuropathic Pain.
Q91906354Rational treatment of chemotherapy-induced peripheral neuropathy with capsaicin 8% patch: from pain relief towards disease modification
Q38958772The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study.
Q38823614Treatment of painful radiculopathies with capsaicin 8% cutaneous patch
Q34548800Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study
Q88099608[Capsaicin 8 % cutaneous patches for phantom limb pain. Results from everyday practice (non-interventional study)]
Q86695248[Current therapy of neuropathic pain]
Q90341000[Long-term effectiveness of topical analgesics]
Q89586323[Treatment of polyneuropathy: autonomic symptoms and pain]

Search more.